Skip to Main
hemonc-homepage-banner-2560x800.jpg

Pediatric Hematology and Oncology

The Division of Pediatric Hematology and Oncology at UT Southwestern is dedicated to advancing care for children and adolescents with cancer and blood disorders. Our program is internationally known for its breadth and depth of expertise in hematology, oncology, and cellular therapy.

In partnership with Children’s Health℠, our faculty provide comprehensive, compassionate care tailored to each patient and family, supported by the latest diagnostic tools and therapeutic innovations.

Our Division is equally committed to academic excellence and scientific discovery. Faculty lead and collaborate on clinical trials, translational research, and laboratory-based studies to improve outcomes and expand treatment options. Through a robust fellowship program and multidisciplinary clinical training, we prepare the next generation of pediatric hematologist-oncologists to lead in both patient care and research.

Highlights of our Division include:

  • One of the 10 largest programs of its kind in the U.S.
  • Multidisciplinary faculty with expertise spanning oncology, hematology, and cellular and immunotherapy
  • Innovative clinical therapies, including ex vivo gene therapy and MIBG therapy for neuroblastoma
  • Robust basic/translational research programs, with seven distinct PIs/research programs

By the Numbers

Faculty and Staff icon

Faculty

  • 44 faculty
Fellowships icon

Clinical

  • 2 clinical sites
  • 31,000+ patient encounters
Doctors in Training icon

Education

  • 9 fellows; rotating residents and students
Clinical Studies Icon

Research

  • 35 active awards
  • 127 active clinical trials

Leadership

Andrew Y. Koh, M.D.

Professor

Chief, Division of Pediatric Hematology and Oncology

Grant A. Dove Distinguished Chair for Research in Oncology

Medical Director, Pauline Allen Gill Center for Cancer and Blood Disorders